(Q51076088)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23574760%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

title

Bile acid malabsorption deactivates pregnane X receptor in patients with Crohn's disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23574760%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23574760%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

author name string

Junichi Iwamoto

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23574760%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Yoshifumi Saito

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23574760%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Teruo Miyazaki

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23574760%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Tadashi Ikegami

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23574760%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Yasushi Matsuzaki

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23574760%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

publication date

1 May 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23574760%20AND%20SRC:MED&resulttype=core&format=json

Inflammatory Bowel Diseases

28 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23574760%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

volume

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23574760%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23574760%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

page(s)

1278-1284

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23574760%20AND%20SRC:MED&resulttype=core&format=json

Inflammatory Bowel Disease

28 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E318281F423

Inflammatory bowel disease: clinical aspects and established and evolving therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E318281F423

Differential regulation of hepatic CYP2B6 and CYP3A4 genes by constitutive androstane receptor but not pregnane X receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E318281F423

The human orphan nuclear receptor PXR is activated by compounds that regulate CYP3A4 gene expression and cause drug interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E318281F423

Mutual repression between steroid and xenobiotic receptor and NF-kappaB signaling pathways links xenobiotic metabolism and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E318281F423

Pregnane-X-receptor mediates the anti-inflammatory activities of rifaximin on detoxification pathways in intestinal epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E318281F423

Inhibition of NF-κB by a PXR-dependent pathway mediates counter-regulatory activities of rifaximin on innate immunity in intestinal epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E318281F423

Pregnane X receptor (PXR/NR1I2) gene haplotypes modulate susceptibility to inflammatory bowel disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E318281F423

Adjunctive antibiotic therapy with rifaximin may help reduce Crohn's disease activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E318281F423

Therapeutic role of rifaximin in inflammatory bowel disease: clinical implication of human pregnane X receptor activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E318281F423

Hepatic metabolism of cholesterol in Crohn's disease. Effect of partial resection of ileum.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E318281F423

Bile acid malabsorption in inflammatory bowel disease: assessment by serum markers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E318281F423

Circulating intestinal fibroblast growth factor 19 has a pronounced diurnal variation and modulates hepatic bile acid synthesis in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E318281F423

An essential role for nuclear receptors SXR/PXR in detoxification of cholestatic bile acids.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E318281F423

The nuclear receptor PXR is a lithocholic acid sensor that protects against liver toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E318281F423

4β-Hydroxycholesterol, an endogenous marker of CYP3A4/5 activity in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E318281F423

Highly sensitive and specific analysis of sterol profiles in biological samples by HPLC-ESI-MS/MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E318281F423

Transport of side-chain oxidized oxysterols in the human circulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E318281F423

Significance of plasma 7alpha-hydroxy-4-cholesten-3-one and 27-hydroxycholesterol concentrations as markers for hepatic bile acid synthesis in cholesterol-fed rabbits

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E318281F423

Cholesterol 25-hydroxylation activity of CYP3A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E318281F423

Contribution of intestinal cytochrome p450-mediated metabolism to drug-drug inhibition and induction interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E318281F423

Highly sensitive quantification of 7alpha-hydroxy-4-cholesten-3-one in human serum by LC-ESI-MS/MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E318281F423

Farnesoid X receptor activation inhibits inflammation and preserves the intestinal barrier in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E318281F423

Farnesoid X receptor (FXR) activation and FXR genetic variation in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E318281F423

Definition of a novel growth factor-dependent signal cascade for the suppression of bile acid biosynthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E318281F423

10.1097/MIB.0B013E318281F423

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23574760%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

1 reference